Cerus Corporation (CERS)
NASDAQ: CERS · Real-Time Price · USD
2.090
-0.060 (-2.79%)
At close: Dec 19, 2025, 4:00 PM EST
2.090
0.00 (0.00%)
After-hours: Dec 19, 2025, 5:39 PM EST
Cerus Revenue
Cerus had revenue of $60.24M in the quarter ending September 30, 2025, with 18.91% growth. This brings the company's revenue in the last twelve months to $225.97M, up 14.18% year-over-year. In the year 2024, Cerus had annual revenue of $201.32M with 7.78% growth.
Revenue (ttm)
$225.97M
Revenue Growth
+14.18%
P/S Ratio
2.04
Revenue / Employee
$316,176
Employees
630
Market Cap
401.46M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 201.32M | 14.52M | 7.78% |
| Dec 31, 2023 | 186.80M | -1.52M | -0.81% |
| Dec 31, 2022 | 188.32M | 28.80M | 18.05% |
| Dec 31, 2021 | 159.52M | 45.27M | 39.62% |
| Dec 31, 2020 | 114.25M | 20.48M | 21.83% |
| Dec 31, 2019 | 93.77M | 17.72M | 23.30% |
| Dec 31, 2018 | 76.05M | 24.73M | 48.17% |
| Dec 31, 2017 | 51.33M | 12.05M | 30.68% |
| Dec 31, 2016 | 39.28M | 5.05M | 14.76% |
| Dec 31, 2015 | 34.22M | -2.19M | -6.02% |
| Dec 31, 2014 | 36.42M | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | 36.79M | 3.74M | 11.32% |
| Dec 31, 2011 | 33.04M | 9.94M | 42.99% |
| Dec 31, 2010 | 23.11M | 5.13M | 28.51% |
| Dec 31, 2009 | 17.98M | 1.48M | 8.94% |
| Dec 31, 2008 | 16.51M | 5.46M | 49.47% |
| Dec 31, 2007 | 11.04M | -19.27M | -63.56% |
| Dec 31, 2006 | 30.31M | 16.81M | 124.57% |
| Dec 31, 2005 | 13.50M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
CERS News
- 9 days ago - Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America - Business Wire
- 25 days ago - Cerus: IFC Growth And RBC Optionality - Seeking Alpha
- 6 weeks ago - Cerus Corporation (CERS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance - Business Wire
- 2 months ago - Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting - Business Wire
- 2 months ago - Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025 - Business Wire
- 4 months ago - The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions - Business Wire
- 4 months ago - Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025 - Business Wire